Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03635333 · ClinicalTrials.gov registry record · Phase 1
Effects of E-Cigarette Flavors on Adults TCORS 2.0
A Phase 1 study, sponsored by Yale University.
- Completed
- Registry status
- Phase 1
- Development phase
- 130
- Enrollment target
NCT03635333: Completed Phase 1 study, sponsored by Yale University.
NCT03635333 is a Phase 1 study that has completed, run by Yale University. The registered enrollment target is 130 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (117% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03635333, a Phase 1 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 130 participants
- Enrollment target
Study Summary
This study looks at the effects of flavors when administered with nicotine in e-cigarettes in younger and older adult cigarette smokers.
Primary Outcome
The Labeled Hedonic Scale (LHS; Lim et al., 2009) will be used to ask about liking and wanting of the e-cigarette (one item VAS scale \[range -100 to 100\] with ratings from most disliked sensation imaginable to most liked sensation imaginable with higher values indicating greater liking)
Interventions
- DRUG Nicotine
- DRUG Flavor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2019-05-14 |
| Est. Completion | 2023-07-12 |
| Phase | Phase 1 |
What the finished NCT03635333 record still lists
NCT03635333 is an interventional study that assigns participants to a tested intervention. The registered 130 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (117% higher).
The record links to 0 conditions, and to 2 interventions - of which Nicotine is the first listed.
NCT03635333 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03635333 about?
NCT03635333 is a clinical study titled "Effects of E-Cigarette Flavors on Adults TCORS 2.0". This study looks at the effects of flavors when administered with nicotine in e-cigarettes in younger and older adult cigarette smokers.
What is the current status of trial NCT03635333?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 130 participants. The study started on 2019-05-14. Estimated completion is 2023-07-12.
What interventions are being tested in trial NCT03635333?
The interventions under investigation include: Nicotine (DRUG), Flavor (DRUG).
Who is sponsoring clinical trial NCT03635333?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03635333's enrollment target sits among peer trials
130 439th of 2000 higher than 1,550 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01492036 · 130 participants
Long-Term Follow-Up of Recipient of Gene Transfer Research
- NCT01631617 · 130 participants · Phase 2
Effects of Treatments on Atopic Dermatitis
- NCT02368041 · 130 participants
Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure
- NCT02604277 · 130 participants · NA
Suicidal Behavior in Patients Diagnosed With Bipolar Disorder
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI